Lilly, food and drug administration
Lilly sues online vendors, medical spa over copycat weight-loss drugs
Eli Lilly said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, the main ingredient in its popular weight-loss medicine Zepbound, including in the form of dissolvable tablets.
Eli Lilly & Co. closed $63.38 below its 52-week high ($972.53), which the company reached on August 22nd.
U.K. regulators will reportedly recommend that the National Health Service not cover Eli Lilly’s (NYSE:LLY) donanemab for the ...
A group of U.S. senators are digging into the direct-to-consumer telehealth platforms launched by Eli Lilly and Pfizer this ...
Britain's National Health Service (NHS) will block Eli Lilly's Alzheimer's drug donanemab on Wednesday, deeming it too ...
Medpage Today on MSN10h
Why Hospital Gowns Are Ugly; Mass Food Poisoning in Maryland; Eli Lilly Files SuitIn Washington state, four agricultural workers tested presumptively positive for avian influenza after contact with infected ...
The News Leader (Staunton) on MSN2h
Five Waynesboro residents ask judge to force Lilly and Mares to certify upcoming electionA counter lawsuit asking a judge to force two Waynesboro Board of Election members to certify the Nov. 5 election was filed ...
Dick Durbin (D-Ill.) demanded answers from Pfizer and Eli Lilly about their relationships with the telehealth prescribers ...
Lilly Ledbetter may have lost in the court of law, but she won in the court of public opinion as she brought attention to the ...
A group of lawmakers led by Senator Dick Durbin are seeking answers from Pfizer (PFE) and Eli Lilly (LLY) about their relationships with the ...
Led by Sen. Dick Durbin of Illinois, senators question if direct-to-consumer website telehealth deals are a new way around ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback